Impact of Febuxostat on Renal Function in Gout Patients With Moderate-to-Severe Renal Impairment

Preservation of Renal Function during Gout Treatment with Febuxostat: A Quantitative Study

(2013) Andrew Whelton et al.   POSTGRADUATE MEDICINE

Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008

(2012) Yanyan Zhu et al.   AMERICAN JOURNAL OF MEDICINE

Renal Function in Gout

(2012) Andrew Whelton et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Reduced Glomerular Function and Prevalence of Gout: NHANES 2009–10

(2012) Eswar Krishnan   PLoS One

Gout and its comorbidities: implications for therapy

(2012) L. K. Stamp et al.   RHEUMATOLOGY

2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

(2012) Dinesh Khanna et al.   ARTHRITIS CARE & RESEARCH

Uric Acid Levels Predict Future Development of Chronic Kidney Disease

(2011) Hiroo Sonoda et al.   AMERICAN JOURNAL OF NEPHROLOGY

Association of Uric Acid With Change in Kidney Function in Healthy Normotensive Individuals

(2010) Gianni Bellomo et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

(2010) Michael A Becker et al.   ARTHRITIS RESEARCH & THERAPY

Risk Factors for End-Stage Renal Disease

(2009) Chi-yuan Hsu et al.   ARCHIVES OF INTERNAL MEDICINE

Clinical Efficacy and Safety of Successful Longterm Urate Lowering with Febuxostat or Allopurinol in Subjects with Gout

(2009) M. A. BECKER et al.   JOURNAL OF RHEUMATOLOGY

Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study

(2009) H. R. Schumacher et al.   RHEUMATOLOGY

Elevated Uric Acid Increases the Risk for Kidney Disease

(2008) R. P. Obermayr et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY